COURTNEY WHITTLE: Open Payments
NPI 1801137039 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 77 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,315 · 2025 $1,750
Food & beverage: $1,650Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $337 |
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Verona Pharma, Inc. | 8 | $201 |
| HARMONY BIOSCIENCES LLC | 6 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $166 |
| Amgen Inc. | 6 | $141 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Viatris Specialty LLC | 4 | $96 |
| Inspire Medical Systems, Inc. | 1 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
Products named: NUCALA, Ohtuvayre, TEZSPIRE, GLASSIA, AIRSUPRA, Sunosi, YUPELRI, INSPIRE.
Industry payments across CT — which companies pay providers there.
